Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13671)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(36): 8112-8122 [PMID: 27688653 DOI: 10.3748/wjg.v22.i36.8112] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i36/8112.htm |
| Number | Citing Articles |
| 1 |
Evaluation of hepcidin and its relationship with iron in non-alcoholic fatty liver disease. Biomedicine 2022; 42(1): 173 doi: 10.51248/.v42i1.680
|
| 2 |
Sandra Maria Barbalho, Lucas Fornari Laurindo, Ricardo José Tofano, Uri Adrian Prync Flato, Claudemir G. Mendes, Ricardo de Alvares Goulart, Ana Maria Gonçalves Milla Briguezi, Marcelo Dib Bechara. Dysmetabolic Iron Overload Syndrome: Going beyond the Traditional Risk Factors Associated with Metabolic Syndrome. Endocrines 2023; 4(1): 18 doi: 10.3390/endocrines4010002
|
| 3 |
Anne Kaul, Annette Masuch, Kathrin Budde, Gabi Kastenmüller, Anna Artati, Jerzy Adamski, Henry Völzke, Matthias Nauck, Nele Friedrich, Maik Pietzner. Molecular Fingerprints of Iron Parameters among a Population-Based Sample. Nutrients 2018; 10(11): 1800 doi: 10.3390/nu10111800
|
| 4 |
T. Antofiichuk, O. Khukhlina, M. Antofiichuk, N. Kaspruk. Metabolic preconditions for the formation andprogression of steatohepatitis of alcoholic,mixed, non-alcoholic aetiology and their comorbidity withobesity and anaemic conditions. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2023; 19(3): 169 doi: 10.22141/2224-0721.19.3.2023.1267
|
| 5 |
Matthew T. Goodus, Kaitlin E. Carson, Andrew D. Sauerbeck, Priyankar Dey, Anthony N. Alfredo, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue. Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits. Experimental Neurology 2021; 342: 113725 doi: 10.1016/j.expneurol.2021.113725
|
| 6 |
Hye Young Kim, Chul Hee Park, Joon Beom Park, Kangeun Ko, Mi Hwa Lee, Jin Chung, Young Hyun Yoo. Hepatic STAMP2 alleviates polychlorinated biphenyl‐induced steatosis and hepatic iron overload in NAFLD models. Environmental Toxicology 2022; 37(9): 2223 doi: 10.1002/tox.23589
|
| 7 |
Marià Alemany. The Metabolic Syndrome, a Human Disease. International Journal of Molecular Sciences 2024; 25(4): 2251 doi: 10.3390/ijms25042251
|
| 8 |
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(1): 354 doi: 10.1016/j.jcmgh.2021.01.019
|
| 9 |
Hana’a Mahmoud Al-Dayyat, Yaser Mohammed Rayyan, Reema Fayez Tayyem. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(4): 569 doi: 10.1016/j.dsx.2018.03.016
|
| 10 |
Jacek Baj, Beata Kowalska, Aleksandra Barbachowska, Alicja Forma, Michał Flieger, Dariusz Majerek, Grzegorz Teresiński, Wojciech Flieger, Piero Portincasa, Grzegorz Buszewicz, Elżbieta Radzikowska-Büchner, Jolanta Flieger. Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues. Nutrients 2023; 15(15): 3458 doi: 10.3390/nu15153458
|
| 11 |
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep A. Tur, Cristina Bouzas. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review. Nutrients 2023; 15(18): 3987 doi: 10.3390/nu15183987
|
| 12 |
Cenqin Liu, Yishu Chen, Zhixin Zhang, Jiarong Xie, Chaohui Yu, Lei Xu, Youming Li. Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients 2022; 14(24): 5237 doi: 10.3390/nu14245237
|
| 13 |
Zewen Sun, Xingchen Pan, Aowen Tian, Ida Surakka, Tao Wang, Xu Jiao, Shanshan He, Jinfang Song, Xin Tian, Dan Tong, Jianping Wen, Yonggang Zhang, Wanqing Liu, Peng Chen. Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals. JHEP Reports 2023; 5(7): 100744 doi: 10.1016/j.jhepr.2023.100744
|
| 14 |
Yan-Hang Gao, Jing-Yun Wang, Pei-Yan Liu, Jing Sun, Xiao-Mei Wang, Rui-Hong Wu, Xiu-Ting He, Zheng-Kun Tu, Chun-Guang Wang, Hong-Qin Xu, Jun-Qi Niu. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World Journal of Clinical Cases 2018; 6(13): 600-610 doi: 10.12998/wjcc.v6.i13.600
|
| 15 |
Fang Zhong, Liying Guan, Haiyan Lin, Meng Zhao, Yiming Qin, Qihang Li, Zhongshang Yuan, Guang Yang, Ling Gao, Jiajun Zhao. Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.760981
|
| 16 |
Noémie Le Tallec-Estève, Chloé Rousseau, Benoit Desrues, Olivier Loréal, Ronan Thibault. Transferrin saturation is independently associated with the severity of obstructive sleep apnea syndrome and hypoxia among obese subjects. Clinical Nutrition 2021; 40(2): 608 doi: 10.1016/j.clnu.2020.06.007
|
| 17 |
Hye Young Kim, Woo Young Kwon, Joon Beom Park, Mi Hwa Lee, Yoo Jin Oh, SungHwan Suh, Yang Hyun Baek, Jin Sook Jeong, Young Hyun Yoo. Hepatic STAMP2 mediates recombinant FGF21‐induced improvement of hepatic iron overload in nonalcoholic fatty liver disease. The FASEB Journal 2020; 34(9): 12354 doi: 10.1096/fj.202000790R
|
| 18 |
Hong Lu. Inflammatory liver diseases and susceptibility to sepsis. Clinical Science 2024; 138(7): 435 doi: 10.1042/CS20230522
|
| 19 |
Gong Feng, Christopher D. Byrne, Giovanni Targher, Fudi Wang, Ming‐Hua Zheng. Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?. Liver International 2022; 42(7): 1496 doi: 10.1111/liv.15163
|
| 20 |
Jihye Kim, Hye Won Woo, Min-Ho Shin, Yu-Mi Kim, Ji Eun Lim, Bermseok Oh, Dae Sub Song, Insong Koh, Mi Kyung Kim. Genome-wide gene and serum ferritin interaction in the development of type 2 diabetes in adults aged 40 years or older. Nutrition, Metabolism and Cardiovascular Diseases 2022; 32(1): 231 doi: 10.1016/j.numecd.2021.09.028
|
| 21 |
Meilin Zhu, Hanqing Chen, Shuang Zhou, Lingna Zheng, Xue Li, Runxuan Chu, Wei Chen, Bing Wang, Meng Wang, Zhifang Chai, Weiyue Feng. Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload. Nanotoxicology 2021; 15(6): 761 doi: 10.1080/17435390.2021.1919329
|
| 22 |
Ulrike Schmidt, Betül Uluca, Iva Vokic, Barizah Malik, Thomas Kolbe, Caroline Lassnig, Martin Holcmann, Veronica Moreno-Viedma, Bernhard Robl, Carina Mühlberger, Dagmar Gotthardt, Maria Sibilia, Thomas Rülicke, Mathias Müller, Agnes Csiszar, Michael Klymkowsky. Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice. PLOS ONE 2023; 18(9): e0286256 doi: 10.1371/journal.pone.0286256
|
| 23 |
Chenhui Ma, Li Han, Zheying Zhu, Cheng Heng Pang, Guoyu Pan. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochemical Pharmacology 2022; 205: 115242 doi: 10.1016/j.bcp.2022.115242
|
| 24 |
Lanling Xiao, Rui Tang, Jie Wang, Dan Wan, Yulong Yin, Liwei Xie. Gut microbiota bridges the iron homeostasis and host health. Science China Life Sciences 2023; 66(9): 1952 doi: 10.1007/s11427-022-2302-5
|
| 25 |
Eleni Asprouli, Ioanna Panagiota Kalafati, Aikaterini Sakellari, Sotirios Karavoltsos, John Vlachogiannakos, Konstantinos Revenas, Alexander Kokkinos, Manos Dassenakis, George V. Dedoussis, Nick Kalogeropoulos. Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease. Biological Trace Element Research 2019; 188(2): 326 doi: 10.1007/s12011-018-1432-9
|
| 26 |
Clémence Rives, Anne Fougerat, Sandrine Ellero-Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet-Payrastre, Walter Wahli. Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules 2020; 10(12): 1702 doi: 10.3390/biom10121702
|
| 27 |
Jagadish Ramasamy. Diagnostic Utility of Serum Ferritin in Identifying Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Cross-Sectional Study Using National Health and Nutrition Examination Survey (NHANES—2017–2020) Data. Indian Journal of Clinical Biochemistry 2023; doi: 10.1007/s12291-023-01159-8
|
| 28 |
Yves Deugnier, Édouard Bardou-Jacquet, Fabrice Lainé. Dysmetabolic iron overload syndrome (DIOS). La Presse Médicale 2017; 46(12): e306 doi: 10.1016/j.lpm.2017.05.036
|
| 29 |
Jule Filler, Ricarda von Krüchten, Nina Wawro, Lisa Maier, Roberto Lorbeer, Johanna Nattenmüller, Barbara Thorand, Fabian Bamberg, Annette Peters, Christopher L. Schlett, Jakob Linseisen, Susanne Rospleszcz. Association of Habitual Dietary Intake with Liver Iron—A Population-Based Imaging Study. Nutrients 2021; 14(1): 132 doi: 10.3390/nu14010132
|
| 30 |
Xiaoyu Feng, Wenfeng Hu, Yujiao Hong, Linlin Ruan, Yueben Hu, Dan Liu, Zhihao Jia. Taurine Ameliorates Iron Overload-Induced Hepatocyte Injury via the Bcl-2/VDAC1-Mediated Mitochondrial Apoptosis Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/4135752
|
| 31 |
Lin Xiao, Gang Luo, Hongxia Li, Ping Yao, Yuhan Tang. Dietary iron overload mitigates atherosclerosis in high-fat diet-fed apolipoprotein E knockout mice: Role of dysregulated hepatic fatty acid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(10): 159004 doi: 10.1016/j.bbalip.2021.159004
|
| 32 |
Franciele Sabadin Bertol, Bruna Araujo, Brunno Brochado Jorge, Natalino Rinaldi, Luiz Alberto De Carli, Cristiane Valle Tovo. Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. World Journal of Gastrointestinal Surgery 2020; 12(6): 269-276 doi: 10.4240/wjgs.v12.i6.269
|
| 33 |
Hye Young Kim, Young Hyun Yoo. The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review. Biomedicines 2022; 10(9): 2082 doi: 10.3390/biomedicines10092082
|
| 34 |
Nikolaos-Andreas T. Anastasopoulos, Georgios D. Lianos, Vera Tatsi, Anastasia Karampa, Anna Goussia, Georgios K. Glantzounis. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1025 doi: 10.1080/17474124.2020.1802244
|
| 35 |
Gang Luo, Lu Xiang, Lin Xiao. Iron Restriction Alleviates Atherosclerosis in ApoE KO Mice: An iTRAQ Proteomic Analysis. International Journal of Molecular Sciences 2022; 23(24): 15915 doi: 10.3390/ijms232415915
|
| 36 |
Fengping Yao, Xiaohong Cui, Ying Zhang, Zhuchun Bei, Hongquan Wang, Dongxu Zhao, Hong Wang, Yongfei Yang. Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma. Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12918
|
| 37 |
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?. Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
|
| 38 |
Yun Lai, Fen fen Gao, Ruo ting Ge, Rui Liu, Shumei Ma, Xiaodong Liu. Metal ions overloading and cell death. Cell Biology and Toxicology 2024; 40(1) doi: 10.1007/s10565-024-09910-4
|
| 39 |
Hsuan-Hui Wang, Li-Na Liao, Ci-Wen Chang, Yu-Chang Chang, Kang-Hsi Wu, Jiunn-Liang Ko. The alteration of ferritin and transferrin saturation under body mass index and blood pressure in first-time and regular male blood donors in Taiwan. Medicine 2019; 98(22): e15854 doi: 10.1097/MD.0000000000015854
|
| 40 |
Ryan L. Gonciarz, Eric A. Collisson, Adam R. Renslo. Ferrous Iron-Dependent Pharmacology. Trends in Pharmacological Sciences 2021; 42(1): 7 doi: 10.1016/j.tips.2020.11.003
|
| 41 |
Zhengyu Hu, Yan Li, Bingwei Ma, Saifei Lei, Xingchun Wang. Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.952056
|
| 42 |
Qi Song, Junxia Guo, Yanzhen Zhang, Wen Chen. The beneficial effects of taurine in alleviating fatty liver disease. Journal of Functional Foods 2021; 77: 104351 doi: 10.1016/j.jff.2020.104351
|
| 43 |
Ashok Mandala, William J. Chen, Austin Armstrong, Milan R. Malhotra, Sanmathi Chavalmane, Kyle S. McCommis, Anping Chen, Danielle Carpenter, Pratim Biswas, Jaya P. Gnana-Prakasam. PPARα agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and β-catenin signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 321(3): G262 doi: 10.1152/ajpgi.00129.2021
|
| 44 |
Ziping Song, Xinlei Miao, Xiaoling Xie, Guimin Tang, Jiayi Deng, Manling Hu, Shuang Liu, Song Leng. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02129-6
|
| 45 |
A. Yasmin Syauki, Aki Ogawa, Uli Rina Pelegia Simanjuntak, Ingrid Gloria Mangiwa, Miki Doi, Suzumi Kageyama, Rikako Inoue, Nurpudji A. Taslim, Yasuyuki Irie. Protein-Energy Nutritional Status of Moderately Low Protein Intake-Sago Diets Compared to Sufficiently Protein Intake-Rice Diets in Well-Nourished Lowlanders in Papua, Indonesia. F1000Research 2022; 11: 138 doi: 10.12688/f1000research.76099.1
|
| 46 |
Leonardo dos Santos, Sabrina Rodrigues Bertoli, Renata Andrade Ávila, Vinícius Bermond Marques. Iron overload, oxidative stress and vascular dysfunction: Evidences from clinical studies and animal models. Biochimica et Biophysica Acta (BBA) - General Subjects 2022; 1866(9): 130172 doi: 10.1016/j.bbagen.2022.130172
|
| 47 |
Anna M. Hoy, Natasha McDonald, Ross J. Lennen, Matteo Milanesi, Amy H. Herlihy, Timothy J. Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L. Janiczek, Philip S. Murphy, Maurits A. Jansen, Jonathan A. Fallowfield. Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biology Open 2018; 7(7) doi: 10.1242/bio.033910
|
| 48 |
James A. Rioux, Miriam Hewlett, Christa Davis, Chris V. Bowen, Kimberly Brewer, Sharon E. Clarke, Steven D. Beyea. Mapping of fatty acid composition with free‐breathing MR spectroscopic imaging and compressed sensing. NMR in Biomedicine 2021; 34(5) doi: 10.1002/nbm.4241
|
| 49 |
|
| 50 |
Monique Fernandez, Julie Lokan, Christopher Leung, Andrew Grigg. A critical evaluation of the role of iron overload in fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(10): 1873 doi: 10.1111/jgh.15971
|
| 51 |
Matthew T. Goodus, Andrew D. Sauerbeck, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats. Journal of Neurotrauma 2018; 35(24): 2872 doi: 10.1089/neu.2018.5771
|
| 52 |
Junzhao Ye, Ting Feng, Lei Su, Jin Li, Yingying Gong, Xiaoyi Ma. Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review. Helicobacter 2023; 28(6) doi: 10.1111/hel.13030
|
| 53 |
Hong Gao, Zhongmou Jin, Gautam Bandyopadhyay, Gaowei Wang, Dinghong Zhang, Karina Cunha e Rocha, Xiao Liu, Huayi Zhao, Tatiana Kisseleva, David A. Brenner, Michael Karin, Wei Ying. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metabolism 2022; 34(8): 1201 doi: 10.1016/j.cmet.2022.07.006
|
| 54 |
Giuseppina Palladini, Laura Giuseppina Di Pasqua, Marta Cagna, Anna Cleta Croce, Stefano Perlini, Barbara Mannucci, Antonella Profumo, Andrea Ferrigno, Mariapia Vairetti. MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis. International Journal of Molecular Sciences 2022; 23(12): 6817 doi: 10.3390/ijms23126817
|
| 55 |
Sophie Gensluckner, Bernhard Wernly, Florian Koutny, Georg Strebinger, Stephan Zandanell, Lars Stechemesser, Bernhard Paulweber, Bernhard Iglseder, Eugen Trinka, Vanessa Frey, Patrick Langthaler, Georg Semmler, Luca Valenti, Elena Corradini, Christian Datz, Elmar Aigner. Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort. Biomedicines 2024; 12(1): 207 doi: 10.3390/biomedicines12010207
|
| 56 |
Genfeng Yu, Lan Liu, Tao Qin, Yaosheng Luo, Cheng Song, Xingying Chen, Hualin Duan, Yuqi Jiang, Huixian Zeng, Heng Wan, Jie Shen. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study. Biological Trace Element Research 2024; 202(1): 87 doi: 10.1007/s12011-023-03666-4
|
| 57 |
Giuseppina Palladini, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Chen Ling. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. PLOS ONE 2020; 15(12): e0243179 doi: 10.1371/journal.pone.0243179
|
| 58 |
Caroline C. Philpott, Olga Protchenko, Yubo Wang, Lorena Novoa-Aponte, Andres Leon-Torres, Samantha Grounds, Amber J. Tietgens. Iron-tracking strategies: Chaperones capture iron in the cytosolic labile iron pool. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1127690
|
| 59 |
Liao Tan, Qiaoyu Zhou, Jie Liu, Zhaoya Liu, Ruizheng Shi. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017–2018. Food & Function 2023; 14(12): 5653 doi: 10.1039/D2FO04082D
|
| 60 |
Cristina Galarregui, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Víctor de la O, Miguel Ruiz-Canela, Helen Hermana M. Hermsdorff, Josefina Bressan, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet, Itziar Abete. Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. European Journal of Nutrition 2021; 60(4): 1769 doi: 10.1007/s00394-020-02370-6
|
| 61 |
Jun-Wei Wang, Chun-Hua Jin, Jiang-Feng Ke, Yi-Lin Ma, Yu-Jie Wang, Jun-Xi Lu, Mei-Fang Li, Lian-Xi Li. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.942412
|
| 62 |
Hanqing Chen. Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target. Liver Research 2022; 6(4): 203 doi: 10.1016/j.livres.2022.09.003
|
| 63 |
Kaitlin Day, Lucia A. Seale, Ross M. Graham, Barbara R. Cardoso. Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.744825
|
| 64 |
John Wagner, Carine Fillebeen, Tina Haliotis, Edouard Charlebois, Angeliki Katsarou, Jeannie Mui, Hojatollah Vali, Kostas Pantopoulos, Fanis Missirlis. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet. PLOS ONE 2019; 14(8): e0221455 doi: 10.1371/journal.pone.0221455
|
| 65 |
Dina G. Tiniakos, Stratigoula Sakellariou. Non-Alcoholic Fatty Liver Disease. 2020; : 25 doi: 10.1007/978-3-319-95828-6_3
|
| 66 |
Stuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, Lynsey Corless, Quentin M Anstee, Richard J Aspinall, Stephen T Barclay, Paul N Brennan, Tessa M Cacciottolo, Robert D Goldin, Kate Hallsworth, Vanessa Hebditch, Kathryn Jack, Helen Jarvis, Jill Johnson, Wenhao Li, Dina Mansour, Mary McCallum, Ashis Mukhopadhya, Richard Parker, Valerie Ross, Ian A Rowe, Ankur Srivastava, Prarthana Thiagarajan, Alexandra I Thompson, Jeremy Tomlinson, Emmanuel A Tsochatzis, Andrew Yeoman, William Alazawi. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group. The Lancet Gastroenterology & Hepatology 2022; 7(8): 755 doi: 10.1016/S2468-1253(22)00061-9
|
| 67 |
Fransina Ndevahoma, Munyaradzi Mukesi, Phiwayinkosi V. Dludla, Bongani B. Nkambule, Elina P. Nepolo, Tawanda M. Nyambuya. Body weight and its influence on hepcidin levels in patients with type 2 diabetes: A systematic review and meta-analysis of clinical studies. Heliyon 2021; 7(3): e06429 doi: 10.1016/j.heliyon.2021.e06429
|
| 68 |
Zhun Xiao, Minghao Liu, Fangming Yang, Guangwei Liu, Jiangkai Liu, Wenxia Zhao, Suping Ma, Zhongping Duan. Programmed cell death and lipid metabolism of macrophages in NAFLD. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118449
|
| 69 |
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. EBioMedicine 2019; 39: 461 doi: 10.1016/j.ebiom.2018.11.020
|
| 70 |
Magdalena Ogłuszka, Paweł Lipiński, Rafał Radosław Starzyński. Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?. Critical Reviews in Food Science and Nutrition 2022; 62(11): 3002 doi: 10.1080/10408398.2020.1862047
|
| 71 |
Timothy J. Colgan, Ruiyang Zhao, Nathan T. Roberts, Diego Hernando, Scott B. Reeder. Limits of Fat Quantification in the Presence of Iron Overload. Journal of Magnetic Resonance Imaging 2021; 54(4): 1166 doi: 10.1002/jmri.27611
|
| 72 |
Diana Abu-Halaka, Adi Shpaizer, Haim Zeigerman, Joseph Kanner, Oren Tirosh. DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine. Antioxidants 2023; 12(2): 512 doi: 10.3390/antiox12020512
|
| 73 |
Shunming Zhang, Yan Yan, Xu-Fen Zeng, Yeqing Gu, Hongmei Wu, Qing Zhang, Li Liu, Zhenyu Huo, Xiaoqin Luo, Rui Zhang, Emily Sonestedt, Yan Borné, Lu Qi, Tao Huang, Ming-Hua Zheng, Yu-Ming Chen, Kaijun Niu, Le Ma. Associations of the EAT-Lancet reference diet with metabolic dysfunction–associated steatotic liver disease and its severity: A multicohort study. Hepatology 2024; doi: 10.1097/HEP.0000000000001039
|
| 74 |
Meryem KEÇELİ BAŞARAN, Okan GÜRKAN. Analysis of clinical findings and serum micronutrients in pediatric patients with nonalcoholic fatty liver disease. Journal of Health Sciences and Medicine 2023; 6(1): 35 doi: 10.32322/jhsm.1190206
|
| 75 |
V. Nathan Subramaniam. Ironing out Steatohepatitis. Annals of Hepatology 2017; 16(1): 8 doi: 10.5604/16652681.1226809
|
| 76 |
Kexin Sun, Jie V. Zhao, Edmund Anthony Severn Nelson, Vincent Wai Sun Wong, Hugh Simon Hung San Lam, Lai Ling Hui. Iron status and non-alcoholic fatty liver disease: A Mendelian randomization study. Nutrition 2024; 118: 112295 doi: 10.1016/j.nut.2023.112295
|
| 77 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver disease. World Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
|
| 78 |
Octavia Pickett-Blakely, Kimberly Young, Rotonya M. Carr. Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2018; 6(4): 451 doi: 10.1016/j.jcmgh.2018.07.004
|
| 79 |
Edouard Bardou-Jacquet, Houda Hamdi-Roze, Anita Paisant, Marie Decraecker, Marc Bourlière, Nathalie Ganne-Carrié, Victor de Lédinghen, Christophe Bureau. Non-invasive diagnosis and follow-up of hyperferritinaemia. Clinics and Research in Hepatology and Gastroenterology 2022; 46(1): 101762 doi: 10.1016/j.clinre.2021.101762
|
| 80 |
Muhammad Imran, Frédéric Chalmel, Odile Sergent, Bertrand Evrard, Hélène Le Mentec, Antoine Legrand, Aurélien Dupont, Maëlle Bescher, Simon Bucher, Bernard Fromenty, Laurence Huc, Lydie Sparfel, Dominique Lagadic-Gossmann, Normand Podechard. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. Cell Biology and Toxicology 2023; 39(2): 371 doi: 10.1007/s10565-022-09706-4
|
| 81 |
Deepika Suresh, Ashley Li, Matthew J. Miller, Karn Wijarnpreecha, Vincent L. Chen. Associations between metabolic hyperferritinaemia, fibrosis‐promoting alleles and clinical outcomes in steatotic liver disease. Liver International 2024; 44(2): 389 doi: 10.1111/liv.15787
|
| 82 |
Bertha Araceli Marin-Alejandre, Itziar Abete, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Iñigo Navarro-Blasco, Josep A. Tur, Narcisa M. Bandarra, M. Angeles Zulet, J. Alfredo Martinez. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study. Journal of Clinical Lipidology 2020; 14(6): 837 doi: 10.1016/j.jacl.2020.08.007
|
| 83 |
Jianan Zhao, Yiyang Hu, Jinghua Peng. Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy. Cellular & Molecular Biology Letters 2021; 26(1) doi: 10.1186/s11658-021-00254-z
|
| 84 |
Faisal Alsaif, Waleed Al-hamoudi, Maram Alotaiby, Amani Alsadoon, Mohammed Almayouf, Hadeel Almadany, Jawahir Abuhaimed, Noman Ghufran, Ahmed Merajuddin, Imran Ali Khan. Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based Study. Metabolites 2022; 12(12): 1240 doi: 10.3390/metabo12121240
|
| 85 |
Hye Young Kim, Young Hyun Yoo. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression. International Journal of Molecular Sciences 2022; 23(16): 8899 doi: 10.3390/ijms23168899
|
| 86 |
Kang Wang, Guilherme Moura Cunha, Kyle Hasenstab, Walter C. Henderson, Michael S. Middleton, Shelley A. Cole, Jason G. Umans, Tauqeer Ali, Albert Hsiao, Claude B. Sirlin. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data. American Journal of Roentgenology 2023; 221(5): 620 doi: 10.2214/AJR.23.29607
|
| 87 |
Kendra A. Klag, Rickesha Bell, Xuan Jia, Alexandra Seguin, J. Alan Maschek, Mary Bronner, James E. Cox, June L. Round, Diane M. Ward. Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2. Nutrients 2024; 16(12): 1804 doi: 10.3390/nu16121804
|
| 88 |
Sander Lefere, Frank Tacke. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. JHEP Reports 2019; 1(1): 30 doi: 10.1016/j.jhepr.2019.02.004
|
| 89 |
Xiaomin Wang, Xiaojing Zhang, Lin Ma, Shengli Li. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease. Science China Life Sciences 2018; 61(9): 1107 doi: 10.1007/s11427-017-9279-1
|
| 90 |
Anitha Pitchika, Jens‐Peter Kühn, Sabine Schipf, Matthias Nauck, Marcus Dörr, Markus M. Lerch, Marie‐Luise Kromrey, Stephan B. Felix, Marcello R. P. Markus, Wolfgang Rathmann, Henry Völzke, Till Ittermann. Hepatic steatosis and hepatic iron overload modify the association of iron markers with glucose metabolism disorders and metabolic syndrome. Liver International 2021; 41(8): 1841 doi: 10.1111/liv.14868
|
| 91 |
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASH. Nature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
|
| 92 |
Kosha J Mehta, Sebastien Je Farnaud, Paul A Sharp. Iron and liver fibrosis: Mechanistic and clinical aspects. World Journal of Gastroenterology 2019; 25(5): 521-538 doi: 10.3748/wjg.v25.i5.521
|
| 93 |
Fernando Moreto, Artur J. T. Ferron, Fabiane V. Francisqueti‐Ferron, Alfonsina D'Amato, Jessica L. Garcia, Mariane R. Costa, Carol Cristina V. A. Silva, Alessandra Altomare, Camila Renata Correa, Giancarlo Aldini, Ana Lucia A. Ferreira. Differentially expressed proteins obtained by label‐free quantitative proteomic analysis reveal affected biological processes and functions in Western diet‐induced steatohepatitis. Journal of Biochemical and Molecular Toxicology 2021; 35(6): 1 doi: 10.1002/jbt.22751
|
| 94 |
Patrik Nasr, Simone Ignatova, Peter Lundberg, Stergios Kechagias, Mattias Ekstedt. Low hepatic manganese concentrations in patients with hepatic steatosis – A cohort study of copper, iron and manganese in liver biopsies. Journal of Trace Elements in Medicine and Biology 2021; 67: 126772 doi: 10.1016/j.jtemb.2021.126772
|
| 95 |
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. Journal of Agricultural and Food Chemistry 2022; 70(7): 2211 doi: 10.1021/acs.jafc.1c06681
|
| 96 |
James F. Collins, Shireen R.L. Flores, Xiaoyu Wang, Gregory J. Anderson. Physiology of the Gastrointestinal Tract. 2018; : 1451 doi: 10.1016/B978-0-12-809954-4.00060-8
|
| 97 |
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
|
| 98 |
Yoshiharu Muto, Toshiro Moroishi, Kazuya Ichihara, Masaaki Nishiyama, Hideyuki Shimizu, Hidetoshi Eguchi, Kyoji Moriya, Kazuhiko Koike, Koshi Mimori, Masaki Mori, Yuta Katayama, Keiichi I. Nakayama. Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. Journal of Experimental Medicine 2019; 216(4): 950 doi: 10.1084/jem.20180900
|
| 99 |
Ning Li, Yilie Liao, Haipeng Huang, Suneng Fu. Co‐regulation of hepatic steatosis by ferritinophagy and unsaturated fatty acid supply. Hepatology Communications 2022; 6(10): 2640 doi: 10.1002/hep4.2040
|
| 100 |
Baoqiang Zhu, Yuankui Wei, Mingming Zhang, Shiyu Yang, Rongsheng Tong, Wenyuan Li, Enwu Long. Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1286449
|